Retroviral-mediated transfer and expression of the multidrug resistance protein 1 gene (MRP1) protect human hematopoietic cells from antineoplastic drugs

Journal of Hematotherapy and Stem Cell Research

Volumn 8, Issue 5, 1999, Pages 503-514

  Omori, Fusayuki ^a   Juopperi, Tarja ^a,b   Chan, Chi Kin ^a   Chang, Yung Nien ^c   Phipps, Sandrina ^c   Nanji, Shaherose ^a   Zhao, Yongjun ^a   Keith Stewart, A ^b,d   Dubé, Ian D ^a  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c NOVARTIS PHARMA AG   (Switzerland)

^d UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; CD34 ANTIGEN; ETOPOSIDE; FIBRONECTIN; INTERLEUKIN 3; INTERLEUKIN 6; MULTIDRUG RESISTANCE PROTEIN; SCATTER FACTOR; VINCRISTINE; VIRUS VECTOR;

ARTICLE; BONE MARROW SUPPRESSION; GENE EXPRESSION; GENE TRANSFER; GENETIC TRANSDUCTION; HEMATOPOIETIC CELL; MOLONEY MURINE SARCOMA ONCOVIRUS; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS PARTICLE; VIRUS TITRATION;

ANTINEOPLASTIC AGENTS; BASE PAIR MISMATCH; BONE MARROW CELLS; CELL SURVIVAL; DNA-BINDING PROTEINS; GENE TRANSFER TECHNIQUES; GENES, MDR; GENETIC VECTORS; HEMATOPOIETIC STEM CELLS; HUMANS; K562 CELLS; MOLONEY MURINE LEUKEMIA VIRUS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; P-GLYCOPROTEIN; RETROVIRIDAE; TRANSFECTION;

EID: 0032719805     PISSN: 15258165     EISSN: None     Source Type: Journal    
DOI: 10.1089/152581699319957     Document Type: Article

References (51)

1. Murphy D, D Crowther, J Renninson, J Prendiville, M Ranson, M Lind, U Patel, M Dougal, CH Buckley and VR Tindall. (1993). A randomised dose intensity study in ovarian carcinoma comparing chemotherapy given at four week intervals for six cycles with half dose chemotherapy given for twelve cycles. Ann Oncol 4:377-383.
2. Levin L, and WM Hryniuk. (1987). Dose intensity analysis of chemotherapy regimens in ovarian carcinoma. J Clin Oncol 5:756-767.
3. Levin L, R Simon and W Hryniuk. (1993). Importance of multiagent chemotherapy regimens in ovarian carcinoma: dose intensity analysis. J Natl Cancer Inst 85: 1732-1742.
4. Sorrentino BP, SJ Brandt, D Bodine, M Gottesman, I Pastan, A Cline and AW Nienhuis. (1992). Selection of drug-resistant bone marrow cells in vivo after retroviral transfer of human MDR1. Science 257:99-103.
5. Podda S, M Ward, A Himelstein, C Richardson, E de la Flor-Weiss, L Smith, M Gottesman, I Pastan and A Bank. (1992). Transfer and expression of the human multiple drug resistance gene into live mice. Proc Natl Acad Sci USA 89:9676-9680.
6. Sorrentino BP, KT McDonagh, D Woods and D Orlic. (1995). Expression of retroviral vectors containing the human multidrug resistance 1 cDNA in hematopoietic cells of transplanted mice. Blood 86:491-501.
7. Hanania EG, S Fu, I Roninson, Z Zu and AB Deisseroth. (1995). Resistance to Taxol chemotherapy produced in mouse marrow cells by safety-modified retroviruses containing a human MDR-1 transcription unit. Gene Ther 2:279-284.
8. + cells. Blood 84:1408-1414.
9. Hanania EG, S Fu, Z Zu, S Hegewisch-Becker, M Korbling, J Hester, A Durett, M Andreeff, E Mechetner, T Holzmayer, IB Robinson, RE Giles, R Berenson, S Heimfeld and AB Deisseroth. (1995). Chemotherapy resistance to Taxol in clonogenic progenitor cells following transduction of CD34 selected marrow and peripheral blood cells with a retrovirus that contains the MDR-1 chemotherapy resistance gene. Gene Ther 2:285-294.
10. Fruehauf S, DA Breems, S Knaan-Shanzer, KB Brouwer, R Haas, B Lowenberg, K Nooter, RE Ploemacher, D Valerio and JJ Boesen. (1996). Frequency analysis of multidrug resistance-1 gene transfer into human primitive hematopoietic progenitor cells using the cobblestone area-forming cell assay and detection of vector-mediated P-glycoprotein expression by rhodamine-123. Hum Gene Ther 7:1219-1231.
11. Deisseroth AB, J Kavanagh and R Champlin. (1994). Use of safety-modified retroviruses to introduce chemotherapy resistance sequences into normal hematopoietic cells for chemoprotection during the therapy of ovarian cancer: a pilot trial. Hum Gene Ther 5:1507-1522.
12. O'Shaughnessy JA, KH Cowan, AW Nienhuis, KT McDonagh, BP Sorrentino, CE Dunbar, Y Chiang, W Wilson, B Goldspiel, D Kohler, M Cottler-Fox, S Leitman, M Gottesman, I Pastan, A Denicoff, M Noone, and R Gress (1994). Retroviral mediated transfer of the human multidrug resistance gene (MDR-1) into hematopoietic stem cells during autologous transplantation after intensive chemotherapy for metastatic breast cancer. Hum Gene Ther 5:891-911.
13. Hesdorffer C, K Antman, A Bank, M Fetell, G Mears and M Begg. (1994). Human MDR gene transfer in patients with advanced cancer. Hum Gene Ther 5:1151-1160.
14. Raderer M, and W Scheithauer. (1993). Clinical trials of agents that reverse multidrug resistance. A literature review. Cancer 72:3553-3563.
15. Motzer RJ, P Lyn, P Fischer, P Lianes, RL Ngo, C Cordon-Cardo and JP O'Brien. (1995). Phase I/II trial of dexverapamil plus vinblastine for patients with advanced renal cell carcinoma. J Clin Oncol 13:1958-1965.
16. Bunting KD, J Galipeau, D Topham, E Benaim and BP Sorrentino. (1998). Transduction of murine bone marrow cells with an MDR1 vector enables ex vivo stem cell expansion, but these expanded grafts cause a myeloproliferative syndrome in transplanted mice. Blood 92:2269-2279.
17. Cole SP, G Bhardwaj, JH Gerlach, JE Mackie, CE Grant, KC Almquist, AJ Stewart, EU Kurz, AM Duncan and RG Deeley. (1992). Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 258:1650-1654.
18. Grant CE, G Valdimarsson, DR Hipfner, KC Almquist, SP Cole and RG Deeley. (1994). Overexpression of multidrug resistance-associated protein (MRP1) increases resistance to natural product drugs. Cancer Res 54:357-361.
19. r 190,000 multidrug resistance protein, MRP1, with monoclonal antibodies. Cancer Res 54:5788-5792.
20. Cole SP, KE Sparks, K Fraser, DW Loe, CE Grant, GM Wilson and RG Deeley. (1994). Pharmacological characterization of multidrug resistant MRP1-transfected human tumor cells. Cancer Res 54:5902-5910.
21. Barrand MA, AC Heppell-Parton, KA Wright, PH Rabbitts and PR Twentyman. (1994). A 190-kilodalton protein overexpressed in non-P-glycoprotein-containing multidrug-resistant cells and its relationship to the MRP1 gene. J Natl Cancer Inst 86:110-117.
22. Zaman GJ, MJ Flens, MR van Leusden, M de Haas, HS Mulder, J Lankelma, HM Pinedo, RJ Scheper, F Baas, HJ Broxterman and P Borst. (1994). The human multidrug resistance-associated protein MRP1 is a plasma membrane drug-efflux pump. Proc Natl Acad Sci USA 91:8822-8826.
23. D'Hondt V, M Caruso and A Bank. (1997). Retrovirus-mediated gene transfer of the multidrug resistance-associated protein (MRP1) cDNA protects cells from chemotherapeutic agents. Hum Gene Ther 8:1745-1751.
24. Machiels JP, A Govaerts, T Guillaume, B Bayat, A Feyens, E Lenoir, J Goeminne, S Cole, R Deeley, M Caruso, A Bank, M Symann, V D'hondt. (1999). Retrovirus-mediated gene transfer of the human multidrug resistance-associated protein into hematopoietic cells protects mice from chemotherapy induced leukopenia. Hum Gene Ther 10:801-811.
25. Beck-Engeser G, C Stocking, U Just, L Albritton, M Dexter, E Spooncer and W Ostertag. (1991). Retroviral vectors related to the myeloproliferative sarcoma virus allow efficient expression in hematopoietic stem and precursor cell lines, but retroviral infection is reduced in more primitive cells. Hum Gene Ther 2:61-70.
26. Miller AD. (1992). Retroviral vectors. Curr Top Microbiol Immunol 158:1-24.
27. Markowitz D, S Goff and A Bank. (1988). A safe packaging line for gene transfer: separating viral genes on two different plasmids. J Virol 62:1120-1124.
28. Miller AD, and C Buttimore. (1986). Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol Cell Biol 6:2895-2902.
29. Lozzio CB, and BB Lozzio. (1975). Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. Blood 45:321-334.
30. Moritz T, VP Patel and DA Williams. (1994). Bone marrow extracellular matrix molecules improve gene transfer into human hematopoietic cells via retroviral vectors. J Clin Invest 93:1451-1457.
31. + hematopoietic cells. Hum Gene Ther 8:2193-2206.
32. Gerard CJ, MJ Arboleda, G Solar, JJ Mule and WG Kerr. (1996). A rapid and quantitative assay to estimate gene transfer into retrovirally transduced hematopoietic stem/progenitor cells using a 96-well format PCR and fluorescent detection system universal for MMLV-based proviruses. Hum Gene Ther 7:343-354.
33. Gottesman MM, and I Pastan. (1993). Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 62:385-427.
34. Hooijberg JH, HJ Broxterman, M Kool, YG Assaraf, GJ Peters, P Noordhuis, RJ Scheper, P Borst, HM Pinedo and G Jansen. (1999). Anitfolate resistance mediated by the multidrug resistance protein MRP11 and MRP12. Hum Gene Ther 59:2532-2535.
35. Li Y, E Golemis, JW Hartley and N Hopkins. (1987). Disease specificity of nondefective Friend and Moloney murine leukemia viruses is controlled by a small number of nucleotides. J Virol 61:693-700.
36. Speck NA, B Renjifo, E Golemis, TN Fredrickson, JW Hartley and N Hopkins. (1990). Mutation of the core or adjacent LVb elements of the Moloney murine leukemia virus enhancer alters disease specificity. Genes Dev 4:233-242.
37. Baum C, S Hegewisch-Becker, HG Eckert, C Stocking and W Ostertag. (1995). Novel retroviral vectors for efficient expression of the multidrug resistance (mdr-1) gene in early hematopoietic cells. J Virol 69:7541-7547.
38. Eckert HG, M Stockschlader, U Just, S Hegewisch-Becker, M Grez, A Uhde, A Zander, W Ostertag and C Baum. (1996). High-dose multidrug resistance in primary human hematopoietic progenitor cells transduced with optimized retroviral vectors. Blood 88:3407-3415.
39. Rappa G, A Lorico, RA Flavell and AC Sartorelli. (1997) Evidence that the multidrug resistance protein (MRP1) functions as a co-transporter of glutathione and natural product toxins. Cancer Res 57:5232-5237.
40. Jedlitschky G, I Leier, U Buchholz, M Center and D Keppler. (1994). ATP-dependent transport of glutathione S-conjugates by the multidrug resistance-associated protein. Cancer Res 54:4833-4836.
41. Muller M, C Meijer, GJ Zaman, P Borst, RJ Scheper, NH Mulder, EG de Vries and PL Jansen. (1994). Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport. Proc Natl Acad Sci USA 91:13033-13037.
42. Zaman GJ, J Lankelma, O van Tellingen, J Beijnen, H Dekker, C Paulusma, RP Oude Elferink, F Baas and P Borst. (1995). Role of glutathione in the export of compounds from cells by the multidrug-resistance-associated protein. Proc Natl Acad Sci USA 92:7690-7694.
43. 4 and chemotherapeutic agents in membrane vesicles. J Biol Chem 271:9675-9682.
44. Lorico A, G Rappa, RA Finch, D Yang, RA Flavell and AC Sartorelli. (1997). Disruption of the murine MRP1 (multidrug resistance protein) gene leads to increased sensitivity to etoposide (VP16) and increased levels of glutathione. Cancer Res 57:5238-5242.
45. Isola LM, and JW Gorden. (1986). Systemic resistance to methotrexate in transgenic mice carrying a mutant dihydrofolate reductase gene.. Proc Natl Acad Sci USA 83:9621-9625.
46. Williams DA, K Hsieh, A DeSilvia and RC Mulligan. (1987). Protection of bone marrow transplant recipients from lethal doses of methotrexate by the generation of methotrexate-resistant bone marrow. J Exp Med 166:210-218.
47. Li MX, D Banerjee, SC Zhao, BI Schweitzer, S Mineishi, A Gilboa and JR Bertino. (1994). Development of a reroviral construct containing a human mutated dihydrofolate cDNA for hematopoietic stem cell transduction. Blood 83:3403-3408.
48. + cells to protect them against alkylating agents. Hum Gene Ther 8:1901-1910.
49. Alley JA, LL Dumenco, ON Koc, L Liu and SC Gerson. (1995). Retroviral transduction and expression of the human alkyltransferase cDNA provides nitrosourea resistance to hematopoietic cells. Blood 85:3342-3351.
50. Moritz T, W Mackay, BJ Glassner, DA Williams and L Samson. (1995). Retrovirus-mediated expression of a DNA repair protein in bone marrow protects hemopoietic cells from nitrosourea-induced toxicity in vitro and in vivo. Cancer Res 55:2608-2614.
51. 6-alkylguanine-DNA-alkyltransferase. Blood 87:1957-1961.